$250 | Single User
$500 | Site License
$750 | Enterprise License

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
[Published by Global Data]

Published by Global Data: 24 Aug 2016 | 16349 | In Stock
Related Topics: GlaxoSmithKline , Healthcare

Introduction

Summary

GlaxoSmithKline Pharmaceuticals Limited (GSK India) is a pharmaceutical company that manufactures and markets prescription medicines and vaccines. The prescription medicines range across therapeutic areas such as, analgesic, anti-infective, anti-inflammatory, anti parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, central nervous system (CNS) and oncology. The company offers a range of vaccines for the prevention of hepatitis A, hepatitis B, influenzae, diphtheria, tetanus, pertussis, rotavirus, tetanus toxoid, reduced diphtheria toxoid, human papillomavirus vaccine and others. The company is a subsidiary of GlaxoSmithKline Plc, which has operations across pharmaceuticals, vaccines and consumer health domains. GSK India is headquartered in Mumbai, Maharashtra, India.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Power eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

    GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

    GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

    GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

    GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10

    GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deal Details 11

    Partnerships 11

    University of North Carolina Forms Joint Venture with GlaxoSmithKline 11

    Astellas Pharma Terminates Its Co-Promotion Agreement With GlaxoSmithKline 13

    Acquisition 14

    GlaxoSmithKline Completes Acquisition Of Additional 24.3% Stake In Indian Arm GlaxoSmithKline Pharma For US.03 Billion 14

    GlaxoSmithKline Pharma Acquires LABORATORIOS PHOENIX 16

    GlaxoSmithKline Pharmaceuticals Limited - Key Competitors 17

    Key Employees 18

    Locations And Subsidiaries 19

    Head Office 19

    Appendix 20

    Methodology 20

    About GlobalData 20

    Contact Us 20

    Disclaimer 20

List Of Tables
in GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Published by Global Data]

List of Tables

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Key Facts, 2016 1

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

GlaxoSmithKline Pharmaceuticals Limited, Deals By Therapy Area, 2010 to YTD 2016 8

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10

University of North Carolina Forms Joint Venture with GlaxoSmithKline 11

Astellas Pharma Terminates Its Co-Promotion Agreement With GlaxoSmithKline 13

GlaxoSmithKline Completes Acquisition Of Additional 24.3% Stake In Indian Arm GlaxoSmithKline Pharma For US.03 Billion 14

GlaxoSmithKline Pharma Acquires LABORATORIOS PHOENIX 16

GlaxoSmithKline Pharmaceuticals Limited, Key Competitors 17

GlaxoSmithKline Pharmaceuticals Limited, Key Employees 18

List Of Figures, Charts and Diagrams
in GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Published by Global Data]

List of Figures

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

16349 | GDPH113643D

Number of Pages

20

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
GlaxoSmithKline Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
GlaxoSmithKline K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline K.K. (GSK Japan) a subsidiary of GlaxoSmithKline Plc is a pharmaceutical comp...
10 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline Pharmaceuticals Limited (GSK India) is a pharmaceutical company that manufact...
04 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Plc (GSK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufact...
04 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile
SummaryGlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufact...
24 Feb 2016 by Global Data USD $250 More Info
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
SummaryGlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline Consumer Nigeria) a subsidiary of Glaxo...
09 Jan 2016 by Global Data USD $300 More Info
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
SummaryGlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline Consumer Nigeria) a subsidiary of Glaxo...
08 Nov 2015 by Global Data USD $300 More Info
Physician Views: Is GlaxoSmithKline's BRAF/MEK combo making headway in V600 mutation-positive melanoma patients?
Scope Although the clinical promise of cancer immunotherapies looks poised to see these products gai...
22 Jul 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Assessing the launch of GlaxoSmithKline's Breo Ellipta
Scope It remains early in the launch, but available evidence suggests that GlaxoSmithKline's Breo El...
21 Jan 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Can GlaxoSmithKline strike early with Anoro? / What role will dosing, inhaler type play in uptake of LAMA/LABA combinations for COPD?
ScopeThis year looks set to be one of notable evolution for the US chronic obstructive pulmonary dis...
01 Aug 2013 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)